The epithelial-mesenchymal transition (EMT) correlates with disruption of cell-cell adhesion, loss of cell polarity and development of epithelial cell malignancy. Identifying novel molecules that inhibit EMT has profound potential for developing mechanism-based therapeutics. We previously demonstrated that the endoplasmic reticulum protein 29 (ERp29) is a novel factor that can drive mesenchymal-epithelial transition (MET) and induce cell growth arrest in MDA-MB-231 cells. Here, we show that ERp29 is an important molecule in establishing epithelial cell integrity during the MET. We demonstrate that ERp29 regulates MET in a cell context-dependent manner. ERp29 overexpression induced a complete MET in mesenchymal MDA-MB-231 cells through downregulating the expression of transcriptional repressors (for example, Slug, Snai1, ZEB2 and Twist) of E-cadherin. In contrast, overexpression of ERp29 induces incomplete MET in basal-like BT549 cells in which the expression of EMT-related markers (for example, vimentin; cytokeratin 19 (CK19) and E-cadherin) and the transcriptional repressors of E-cadherin were not altered. However, ERp29 overexpression in both cell-types resulted in loss of filamentous stress fibers, formation of cortical actin and restoration of an epithelial phenotype. Mechanistic studies revealed that overexpression of ERp29 in both cell-types upregulated the expression of TJ proteins (zonula-occludens-1 (ZO-1) and occludin) and the core apical-basal polarity proteins (Par3 and Scribble) at the membrane to enhance cell-cell contact and cell polarization. Knockdown of ERp29 in the epithelial MCF-7 cells decreased the expression of these proteins, leading to the disruption of cell-cell adhesion. Taken together, ERp29 is a novel molecule that regulates MET and epithelial cell integrity in breast cancer cells.
INTRODUCTION
Epithelial-mesenchymal transition (EMT) is a morphogenetic program essential for epithelial plasticity during embryonic development and tissue remodeling. 1 The cellular machinery of EMT can be activated in pathologies such as inflammation, organ fibrosis and cancer progression. 2 During EMT, epithelial cells: (1) lose their junctions, for example, adherens junctions (AJs) and tight junctions (TJs); (2) lose apical-basal polarity; (3) reorganize their cytoskeletal components and distribution; and (4) acquire migration and invasion abilities. 3 These changes are accompanied by loss of AJ proteins (for example, E-cadherin), TJ proteins (for example, zonula-occludens (ZO-1) and occludins) and epithelial cytokeratins (for example, cytokeratin 19; CK19) and the gain of mesenchymal markers (for example, vimentin and fibronectin) and filamentous (F)-actin. 4 The involvement of EMT in cancer progression has been proposed to be important for the 'escape' of tumor cells from the primary site and therefore promotes metastasis. 4 Conversely, mesenchymal cells can also regain a fully differentiated epithelial phenotype via the mesenchymal-epithelial transition (MET). 5, 6 The MET may also have a role in carcinogenesis by mediating the establishment of distant metastatic tumors at secondary sites. 7 However, this theory remains controversial and needs to be experimentally demonstrated. 3, 8, 9 The process of EMT is promoted by the coordination of a complex network of various signaling pathways, including those mediated through transforming growth factor-b, Notch, fibroblast growth factor, Wnt and integrin signaling. 6, [10] [11] [12] One of the key characteristics of EMT regulated by these pathways is downregulation of the epithelial cell marker, E-cadherin, which mediates cell-cell contacts in AJs. 13 Regulation of E-cadherin expression is mediated via transcriptional repressors including zinc-finger proteins (for example, Snai1 and Slug), zinc-finger E-box-binding proteins (for example, ZEB1/2), the basic helix-loophelix proteins (for example, Twist) and Ets-1. [14] [15] [16] Importantly, knockdown of these repressors induces the re-expression of E-cadherin 17 and restores the epithelial phenotype. 18 Clinically, loss of E-cadherin is widely observed in invasive and metastatic carcinoma and correlates with the aggressiveness of tumors and poor survival rates in cancer patients. 19 This observation is consistent with the observation that enhanced expression of the transcriptional repressors of E-cadherin is associated with tumor progression and lymph node metastasis.
'identity' to apical and basolateral domains. These polarity proteins are organized as three major complexes, namely the partitioning-defective (Par) complex (Par3, Par6 and atypical protein kinase (aPKC)), the Crumbs complex (Crumbs, Pals 1/Stardust and Patj/Disc lost) and the Scribble complex (Scribble, lethal giant larvae (Lgl) and Disc large (Dlg)). 24 The Par and Crumbs complexes cooperate in establishing the apical domain and in the assembly of TJs, whereas the Scribble complex has a key role in the definition of the basolateral plasma membrane domain. 25, 26 The formation of TJs is closely linked to the proper polarization of cells during the establishment of epithelial architecture. 26 Accumulating evidence indicates that the development of human cancer is frequently associated with the failure of epithelial cells to form TJs and to establish correct apico-basal polarity. 27 Endoplasmic reticulum protein 29 (ERp29) is a chaperone protein that functions in the unfolding and escort of secretory proteins. 28 Its function in cancer cells has been actively addressed, although further investigation is required to elucidate its roles. 29, 30 Recent studies have demonstrated significant involvement of ERp29 in cancer cell survival against genotoxic stress induced by doxorubicin and radiation, [31] [32] [33] and cell growth arrest through the activation of p38 and upregulation of the ER stress protein, p58 IPK34 Importantly, ERp29 was found to regulate MET accompanied with cytoskeletal reorganization and epithelial morphogenesis 30 and also to modulate Connexin43 trafficking and gap junction formation. 35 These novel findings provide a clue to a potential role of ERp29 in establishing epithelial cell architecture.
In this study, we further investigated the mechanism(s) of ERp29 in regulating MET and cell polarity in both mesenchymallike MDA-MB-231 cells and basal-like BT549 cells using ERp29-overexpressing stable clones. Both these cell-types belong to the basal-like subtype of breast cancer cells. 36 However, MDA-MB-231 cells were derived from a pleural effusion of invasive ductal carcinoma and have undergone complete EMT and acquired mesenchymal features. 37 In contrast, BT549 cells were originally derived from a primary papillary invasive ductal carcinoma and have undergone incomplete EMT. 37 We showed that ERp29 induces a typical epithelial-like phenotype in these cell models and modulates MET in a cell context-dependent manner. Importantly, overexpression of ERp29 enhanced the expression and membrane localization of proteins involved in TJ formation and cell polarity, whereas knockdown of ERp29 in epithelial-like MCF-7 cells reduced the expression of these molecules and disrupted cell-cell adhesion. Our studies demonstrate a significant and novel function of ERp29 in regulating epithelial morphogenesis in breast cancer cells.
RESULTS

ERp29 induces phenotypic changes in mesenchymal-like MDA-MB-231 cells and basal-like BT549 cells
Our previous studies have demonstrated a significant role of ERp29 in regulating the MET and inducing a phenotypic change in MDA-MB-231 cells. 30 To further substantiate this function, we established ERp29-overexpressing clones (A and K) of basal-like BT549 cells. Similar to the ERp29-overexpressing clones (B and E) generated in MDA-MB-231 cells (Figure 1a , left panel), both clones A and K selected from the ERp29-transfected BT549 cells showed a B5-6-fold (Po0.01) increase of ERp29 expression compared with the empty-vector-transfected BT549 control cells (Ctrl), as assessed by immunoblotting (Figure 1a, right panel) .
Overexpression of ERp29 in both MDA-MB-231 cells (clones B and E) and BT549 cells (clones A and K) resulted in a change from a spindle-like, fibroblastic morphology in the empty-vector-transfected Ctrl cells to a 'cobble-stone'-like phenotype (Figure 1b , upper panel). F-actin staining with rhodamine-phalloidin showed some rearrangement of the cytoskeleton, leading to the formation of cortical actin in both cell-types in the ERp29-overexpressing clones (Figure 1b, lower panel) . It was reported that phosphorylation of myosin light chain (pMLC) is required for stress fiber formation. 38 Overexpression of ERp29 markedly and significantly (Po0.01-0.001) reduced the level of pMLC relative to the emptyvector-transfected Ctrl cells (Figure 1c) , whereas the basal expression of MLC was not significantly (P40.05) changed in either MDA-MB-231 or BT549 cells. These observations indicated that ERp29 may induce loss of stress fibers through downregulating phosphorylation of MLC. In line with the notion that loss of stress fibers is an important step in progression of the MET, 12 the phenotypic change driven by ERp29 overexpression in BT549 cells implicates an occurrence of the MET, similar to that observed in ERp29-overexpressing MDA-MB-231 cells.
ERp29 induces complete MET in mesenchymal-like MDA-MB-231 cells and incomplete MET in basal-like BT549 cells To further understand the role of ERp29 in MET regulation, we next examined the effect of ERp29 on the expression of epithelial and mesenchymal cell markers in ERp29-overexpressing BT549 clones (A and K). As shown in Figure 2a , ERp29 overexpression in MDA-MB-231 cells significantly (Po0.001) upregulated the expression of the epithelial markers (E-cadherin and CK19) 4 , and markedly and significantly (Po0.001) reduced the levels of mesenchymal markers (vimentin and fibronectin) 4 relative to the empty-vector-transfected Ctrl cells. The presence of two bands for both E-cadherin and vimentin may be related to post-translational modification of these proteins (Figure 2a Figure 1) . Therefore, ERp29 regulates the efficiency of MET in a cell-type-dependent manner.
Fibronectin is known to regulate cell transition from a quiescent to a proliferative state. 39 Indeed, downregulation of fibronectin by ERp29 in both MDA-MB-231 and BT549 cells suggests a common mechanism that is plausibly responsible, at least in part, for the significant (Po0.01-0.001, ANOVA) inhibition of cellular proliferation by ERp29 overexpression relative to the emptyvector-transfected Ctrl cells (Figure 2b 37 The AJs consist of two basic adhesive units: the cadherin/catenin and nectin/afadin complexes. 40 Particularly, the E-cadherin/b-catenin complex is well described for its contribution to the formation of structured AJs. 41 Given that E-cadherin expression was highly increased and localized in the cytosol and membrane by ERp29 overexpression in mesenchymal dephosphorylation of the protein during its translocation from the nucleus to the membrane. The induced translocation of the nuclear b-catenin (arrow) in empty-vector-transfected Ctrl cells to the membrane (arrows; clones B and E) was demonstrated by immunofluorescence ( Figure 3a) . The ERp29-mediated membrane localization of b-catenin facilitates the assembly of E-cadherin/bcatenin complex and formation of AJs. 40 Similarly, ERp29 overexpression in BT549 cells led to enhanced b-catenin expression in clone A (P ¼ 0.07) and K (Po0.05; Figure 3b ). However, immunofluorescence showed that b-catenin was predominantly localized at the membrane (see arrows) in emptyvector-transfected BT549 Ctrl cells and the overexpression of ERp29 was unable to result in translocation of b-catenin (Figure 3b ). These results indicate that ERp29 regulates the E-cadherin/b-catenin complex in a cell context-dependent manner.
ERp29 upregulates the expression of TJ proteins to restore epithelial-like features in both cell-types Considering the cell-type-dependent regulation of AJs by ERp29 described above, we next examined the expression of molecules involved in TJs (for example, ZO-1 and occludin) in both cell-types. As shown in Figure 4a (Figure 4b ). These results indicate that ERp29 overexpression upregulates these TJ proteins to enhance cell-cell contact and restore epithelial integrity.
ERp29 regulates apical-basal polarity by upregulating the protein expression of apical Par3 and basal Scribble in both cell-types The reconstruction of cell-cell junctions by ERp29 in both MDA-MB-231 and BT549 cells shown above suggests these cells may undergo cellular polarization. Apical-basal polarity in epithelial cells is regulated by the core polarity complexes: Par, Crumbs and the Scribble complex. 22, 25, 26 The Par and Crumb complexes establish apical identity, whereas the Scribble complex defines basal identity. 25, 26 Hence, we examined expression of the Par complex (Par3, Par6, aPKC and Cdc42) and Scribble in both cell-types.
As demonstrated in Figure 5a (left panel), ERp29 overexpression in both MDA-MB-231 and BT549 cells did not significantly (P40.05) affect the mRNA (for densitometry analysis, see Supplementary Figure 3b ) or protein levels of the components of the apical Par complex (Cdc42, Par6 and aPKC) compared with their respective empty-vector-transfected Ctrl cells. It was reported that Cdc42, a small GTPase, is one of the key regulators modulating the expression of Par6 and aPKC 42, 43 and has a critical role in establishing cell polarity in epithelial cells. 44 However, our data suggest that the Cdc42/Par6/aPKC pathway is not involved in ERp29-regulated apical polarity. Nevertheless, while the mRNA level of Par3 in the ERp29-overexpressing clones (B and E; A and K) was comparable to the empty-vectortransfected Ctrl cells (Supplementary Figure 3b) , Par3 protein expression was significantly (Po0.05-0.001) increased by ERp29 overexpression in MDA-MB-231 cells and BT549 cells (Figure 5a , right panel). Thus, ERp29 selectively upregulates Par3 protein expression during epithelial-like morphogenesis.
We then investigated whether ERp29 overexpression could lead to differential cellular distribution of these Par complex proteins. As shown in Figure 5b (upper panel), ERp29 overexpression in these clones (B and E; A and K) in both cell-types resulted in an increase of Par3 expression and its accumulation at the membrane, cytosol and cell-cell junctions (arrows; Figure 5b ) compared with their respective vector-transfected Ctrl cells. In addition, ERp29 overexpression did not markedly alter the expression and distribution of Crumb1, a member of the Crumbs complex, 24 as demonstrated by immunofluorescence staining (Supplementary Figure 4) . Further, immunofluorescence analysis showed that nuclear distribution of Par6, aPKC and Cdc42 in empty-vector-transfected Ctrl cells was not obviously translocated to the membrane and/or the cell-cell junctions by ERp29 overexpression in either MDA-MB-231 or BT549 cells (Supplementary Figure 4) . Taken together, these results indicate that in the apical Par complex, Par3, but not the Cdc42/Par6/aPKC, is a downstream target that is specifically regulated by ERp29. 
In addition to these apical Par complex proteins, the expression and distribution of Scribble, a major component of the basolateral Scribble complex, 24 was assessed. Similar to that observed for ZO-1 and Par3, ERp29 overexpression resulted in a significant (Po0.01-0.001) increase of protein expression of Scribble in both MDA-MB-231 and BT549 cells, while its mRNA level was not altered by ERp29 overexpression compared with empty-vectortransfected Ctrl cells (Figure 5a, Supplementary Figure 3b) . Notably, the ERp29-induced upregulation of Scribble was predominantly localized at the membrane (see arrows) in these ERp29-overexpressing clones (Band E; A and K) compared with the empty-vector-transfected Ctrl cells (Figure 5b, lower panel) . This observation implicates the participation of Scribble in restoration of basolateral polarity induced by ERp29. Taken together, the ERp29-regulated cell polarization is modulated through, at least in part, upregulation and membrane localization of Par3 and Scribble in these cell models.
Knockdown of ERp29 disrupts epithelial integrity in epithelial MCF-7 cells
To further elucidate the role of ERp29 in the regulation of epithelial morphogenesis, epithelial MCF-7 cells were transfected Immunofluorescence staining showed that overexpression of ERp29 led to the enhanced expression and distribution of ZO-1 at the membrane and the cell-cell contacts in the clones of both cell-types (clones B and E, A and K). Similarly, ERp29 overexpression significantly promoted the expression and localization of occludin at the membrane and the cell-cell contacts, particularly in ERp29-overexpressing BT549 cells (A and K). Arrows indicate the localization of ZO-1 (red) and occludin (green) at the membrane and the cell-cell contacts. DAPI (blue) was used for nuclear staining. Original magnification: Â 60. Data represent mean±s.d. based on three independent experiments. **Po0.01; ***Po0.001.
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with ERp29-targeted shRNA to knockdown endogenous ERp29 (Figure 6a ). We previously reported that ERp29 knockdown in MCF-7 cells increased cell proliferation and cell migration/ invasion, and led MCF-7 cells to undergo EMT through reducing E-cadherin and upregulating vimentin expression. 30 In the current studies using MCF-7 cells, ERp29 depletion by shRNA significantly (Po0.05-0.01) reduced protein expression of ZO-1, Par3 and Scribble relative to the scrambled shRNA Ctrl cells (shCtrl; Figure 6a ), while their mRNA levels were not significantly (P40.05) altered (Figure 6a ). This result further supports a role of ERp29 in regulating protein synthesis and/or protein stability of ZO-1, Par3 and Scribble. Here we also show that ERp29 We have also demonstrated that ERp29-regulated MET occurred in a cell context-dependent manner. In mesenchymal-like MDA-MB-231 cells, ERp29 overexpression induced a complete MET as reflected by the following: (1) ERp29 inhibited the transcriptional repressors of E-cadherin, thus leading to the re-expression of E-cadherin; (2) ERp29 markedly upregulated the expression of the epithelial cell marker CK19; (3) ERp29 downregulated the level of mesenchymal cell markers (vimentin and fibronectin); and (4) ERp29 significantly reduced cell proliferation, migration and invasion (Figure 2b, Supplementary Figure 1c) . In contrast, ERp29 overexpression in BT549 cells only caused a reduction of fibronectin and an inhibition of cell proliferation (Figures 2a and  b) , indicating partial MET in BT549 cells.
Significantly, we showed that ERp29 overexpression regulated the epithelial phenotype and the formation of cortical actin (Figure 1b) . It has been reported that reorganization of the actin cytoskeleton is tightly linked to myosin-driven contraction initiated by MLC phosphorylation. 38, 45 Notably, pMLC is also involved in the spatial organization of stress fiber contraction and assembly in Madin-Darby canine kidney cells. 46 Our studies demonstrate that, with the loss of stress fibers in the ERp29-overexpressing MDA-MB-231 and BT549 cells, the level of pMLC was markedly reduced. These results suggest that reduction of pMLC has a critical role in ERp29-regulated cortical actin formation and the epithelial phenotype. Recent studies have shown that pMLC is regulated by a network of kinases, including the Ca 2 þ /calmodulin-dependent MLC kinase and Rho-associated, coiled-coil-containing protein kinase. [47] [48] [49] [50] [51] Therefore, it would be of interest to understand whether these kinases are differentially regulated by ERp29 overexpression, leading to reorganization of the cytoskeleton in breast cancer cells.
For the first time, we demonstrate that ERp29 involves the establishment of the apical-junctional complex, which is formed by AJs and TJs. These structures are located in the upper portion of a polarized epithelial cell and are composed of trans-membrane proteins that interact with molecules in adjacent cells. 52 The AJs and TJs are required for integrity of the epithelial phenotype, as well as for epithelial cells to function as a tissue. 53 It has been previously reported that the E-cadherin/b-catenin complex is required for the formation of AJs. 41 In MDA-MB-231 cells, ERp29 overexpression resulted in the increased expression and membrane localization of E-cadherin (Supplementary Figure 1b) and the elevated expression and translocation of b-catenin from the nucleus to the cell membrane (Figure 3a) . In contrast, this molecular process was not initiated in ERp29-overexpressing BT549 cells (Figure 3b) . These results suggest that ERp29 regulates the formation of AJs in a cell context-dependent manner.
On the other hand, ERp29 overexpression led to an increase of TJ components such as ZO-1 and occludin at the membrane and cell-cell junctions in both MDA-MB-231 and BT549 cells (Figures  4a and b) . The role of ERp29 in ZO-1 protein expression and trafficking was further demonstrated in the ERp29-knockdown MCF-7 cells (Figure 6 ). Alterations of TJ protein expression and distribution have been associated with the development of cancer through mechanisms such as the loss of contact inhibition of cell growth. 54 Reduction of ZO-1 and occludin were found to be correlated with poorly defined differentiation, higher metastatic frequency and lower survival rates, 55, 56 indicating a tumor suppressive function of TJs in cancer formation and progression. The translational upregulation of ZO-1 and occludin by ERp29 in these cell models may provide a mechanism of how ERp29 induces tumor suppression in breast cancer. 30 Additionally, the formation of cortical actin filaments is critical for the establishment of AJs and TJs and the regulation of epithelial cell apical-basal polarity. 53 Reorganization of the actin cytoskeleton induces recruitment of ZO-1 to cell periphery before the assembly of junctional complexes between adjacent cells. 57 Hence, the ERp29-induced restoration of ZO-1 expression may be associated with actin reorganization. Taken together, our studies demonstrate a critical role of ERp29 in the formation of the TJ complex and restoration of an epithelial-like phenotype by establishing cell-cell contact.
Consistent with the importance of ERp29 in regulating MET and re-establishment of the epithelial-like phenotype, we demonstrate a significant role of ERp29 in the regulation of cell polarity. In mammals, apico-basal polarity is established and maintained by highly conserved core polarity regulators. The apical complexes (Par and Crumbs) and the basolateral complex (Scribble) are mutually antagonistic, thereby leading to the distribution of proteins in a polarized manner. 58 Herein, the capacity of ERp29 to restore epithelial polarity has been experimentally demonstrated by the upregulation and membrane localization of apical Par3 and basal Scribble in the ERp29-overexpressing MDA-MB-231 and BT549 cells ( Figure 5 ). Furthermore, ERp29 depletion by shRNA in MCF-7 cells resulted in the reduction of these core polarity proteins, leading to the disruption of cell-cell contact and an increased cell spreading ( Figure 6) . A growing amount of data have shown that the deregulation of these core polarity proteins, both in term of mis-localization and decreased expression, may have a causal link to mammalian tumorigenesis. 59 In addition, the association of core polarity proteins with EMT and oncogenesis has been well established 22, 60 and an increasing body of evidence has demonstrated their tumor suppressive capacity in both cell lines and clinical specimens. [61] [62] [63] In agreement with this, the ERp29-induced tumor suppression in breast cancer cells is linked to the integrity of apical-basal polarity that is crucial for the prevention of tumor development. [60] [61] [62] [63] It has been previously demonstrated that polarity proteins are synthesized in the endoplasmic reticulum, transported to the Golgi complex and sorted at the trans-Golgi network into distinct apical and basolateral vesicular routes. 64, 65 Given that ERp29 mediates the folding and secretion of newly synthesized proteins in the ER system, 28 it is plausible that, in addition to increased protein expression of tight junctions and the core polarity complex, ERp29 may also have a critical role in protein trafficking and the maintenance of protein stability to modulate epithelial cell integrity. Therefore, it would be interesting to elucidate whether ERp29 regulates the protein levels of ZO-1, Scribble and Par3 by: (1) inhibiting mRNA degradation; (2) increasing protein translational efficacy; or (3) maintaining protein stability in our breast cancer cell models.
In summary, we have demonstrated that, while ERp29 overexpression regulates the E-cadherin/b-catenin complex in a celltype-dependent manner, ERp29 has a significant role in regulating TJs and cell polarity in both cell-types. As illustrated in Figure 7 Cell culture MDA-MB-231 and MCF-7 cells were cultured in DMEM and BT549 cells were cultured in RPMI-1640. Both of these growth media were supplemented with 10% fetal bovine serum (Invitrogen, Eugene, OR, USA). MDA-MB-231 cells were transfected with pcDNA/ERp29 or pcDNA, and MCF-7 cells were transfected with shRNA/ERp29 or Ctrl shRNA, as previously described. ERp29-overexpressing MDA-MB-231 clones (B and E) and ERp29-knockdown MCF-7 cells and their respective vector-transfected Ctrl cells were maintained in DMEM supplemented with 10% fetal bovine serum and G418 sulfate (2 mg/ml for MDA-MB-231 transfectants and 1 mg/ml for MCF-7 transfectants). ERp29-overexpressing BT549 cells transfected with pcDNA or pcDNA/ERp29 were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and 2 mg/ml G418. Cells were cultured under standard conditions at 37 1C with 5% CO 2 in a humidified incubator.
MATERIALS AND METHODS
Reagents and antibodies
Transfection and selection of stable clones
ERp29-overexpressing BT549 clones were generated by similar procedures as described for MDA-MB-231 cells. 30 Briefly, BT549 cells were transfected with either pcDNA/ERp29 or empty vector pcDNA3.1 using Lipofectamine (Invitrogen) according to the manufacturer's instructions. Transfectants were propagated in RPMI-1640 medium with G418 (2 mg/ml) for 48 h/37 o C and then sub-cultured in Petri dishes after serial dilution. Colonies produced from single cells were transferred into a 96-well plate for cell propagation. Expression of ERp29 was verified by western blotting and two stable clones selected from the ERp29-transfected BT549 cells (clones A and K) were used in experiments.
Cell proliferation
Cell proliferation studies were performed as previously described. 30 Briefly, cells (1 Â 10 3 per well) were seeded in triplicate in 96-well culture plates and cultured for 4 days at 37 o C in a humidified, 5% CO 2 atmosphere. Viable cells were quantified at each 24-h interval using CellTiter 96Aqueous One Solution Cell Proliferation Assay (Promega). The absorbance at 492 nm was measured using an Infinite F200 microplate reader (TECAN Austria GmbH, Grodig, Austria). Cell proliferation using this assay was also validated by manual counts using Trypan blue staining.
Reverse-transcription PCR Total RNA from cells was extracted using NucleoSpin RNA II (MachereyNagel GmbH & Co. KG, Duren, Germany) and cDNA was synthesized using ImProm-II reverse transcriptase (Promega) according to the manufacturer's protocol. The mRNA levels of the indicated genes were amplified using their respective primers listed in Table 1 . RT-PCR was shown to be semiquantitative by an optimization protocol, which demonstrated that it was in the log phase of amplification. As an internal Ctrl, the gene b-actin was amplified and all results expressed relative to its levels. A 5-ml aliquot of each of the PCR products was detected on a 1.8% agarose gel with ethidium bromide staining. The density of each band was analyzed using GeneTools software (Syngene, Frederick, MD, USA).
Western blot analysis
Cell lysates were extracted with RIPA buffer (1% Igepal, 1% sodium deoxycholate, 0.15 M sodium chloride, 0.01 M sodium dodecyl sulfate, pH 7.2 and 2 mM EDTA), supplemented with protease inhibitors (Roche Diagnostics) and phosphatase cocktail inhibitors I and II (1:100, SigmaAldrich). Western blotting was carried out by standard methods, as described. 30, 34 In all experiments, 40 mg of protein was resolved by SDS-PAGE and transferred onto a PVDF membrane. Membranes were blocked with 5% skim milk in Tris-buffered saline buffer with 0.1% Tween 20 (TBST) for 1 h at room temperature and then probed with specific antibodies (that is, Snai1 and Slug, 1:200; fibronectin, occludin or Scribble, 1:500; b-catenin, pMLC, Par3, Twist, ZEB1/2 and ZO-1, 1:1000; ERp29, CK19 and E-cadherin, 1:2500; VIM, 1:5000; b-actin, 1:10 000). HRP-conjugated goatanti-mouse IgG (Promega) or HRP-conjugated goat-anti-rabbit IgG (Promega) was used as secondary antibody. Chemiluminescent signals were visualized using SuperSignal West Pico Chemiluminescent Substrate (Pierce) and signal intensity was analyzed using GeneTools software (Syngene). b-actin was used as a loading Ctrl and the results expressed relative to its levels.
Immunofluorescence and confocal microscopy
Immunofluorescence analysis was performed as previously described. 30 Briefly, cells plated on coverslips were fixed with 4% paraformaldehyde for 20 min at ambient room temperature and permeabilized with 0.1% Triton X-100 for 10 min at room temperature. Cells were then blocked in PBS with 0.2% Tween 20 (PBST) containing 3% (w/v) bovine serum albumin (BSA) for 1 h at room temperature and incubated overnight with the indicated primary antibodies at 4 1C. This procedure was followed by incubation with Table 1 . Primers used for reverse-transcription PCR. Figure 1a) . Raw images were analyzed using Olympus FV10-ASW 1.7 Viewer software (Olympus).
Genes
Statistical analysis
All cell culture experiments were carried out in triplicate and repeated at least twice. Student's t-test or two-way ANOVA was used to analyze the significance of differences. Two-tailed Po0.05 was considered as significant and data are presented as mean ± s.d.
